VITALE, Candida
Dettaglio
VITALE, Candida
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Pubblicazioni
Risultati 1 - 20 di 137 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta |
2 | Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia |
3 | Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia | 2016 | Vitale, Candida; Jabbour, Elias; Lu, Xinyan; Yabe, Mariko; Shamanna, Rashmi Kanagal; Daver, Naval; Pemmaraju, Naveen; Bueso-Ramos, Carlos E.; Takahashi, Koichi* |
4 | Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives | 2019 | Marta Coscia, Candida Vitale, Marco Cerrano, Enrico Maffini, Luisa Giaccone, Mario Boccadoro, Benedetto Bruno |
5 | The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice | 2020 | Cerrano M.; Ruella M.; Perales M.-A.; Vitale C.; Faraci D.G.; Giaccone L.; Coscia M.; Maloy M.; Sanchez-Escamilla M.; Elsabah H.; Fadul A.; Maffini E.; Pittari G.; Bruno B. |
6 | Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma | 2015 | Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M. |
7 | Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs | 2020 | Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M. |
8 | Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib | 2016 | Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.* |
9 | B-cell Acute Lymphoblastic Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Lenalidomide | 2021 | Moritz Fürstenau, Anna Maria Fink, Anke Schilhabel, Jonathan Weiss, Sandra Robrecht, Robert Eckert, Javier de la Serna, Marta Crespo, Marta Coscia, Candida Vitale, Sebastian Böttcher, Gesche Weppner, Matthias Ritgen, Stephan Stilgenbauer, Eugen Tausch, Kirsten Fischer, Michael Hallek, Barbara Eichhorst, Monika Brüggemann, Carmen Diana Herling |
10 | Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo |
11 | BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo |
12 | BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL | 2011 | Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M |
13 | Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo |
14 | Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia | 2015 | Alattar, Mona Lisa; Ciccone, Maria; Gaballa, Mahmoud R.; Vitale, Candida; Badoux, Xavier C.; Manoukian, George; Keating, Michael J.; Kroll, Michael H.; Ferrajoli, Alessandra* |
15 | Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia | 2014 | Candida Vitale; Mona Lisa Alattar; Maria Ciccone; Mahmoud R Gaballa; Xavier C Badoux; George Manoukian; Michael J Keating; Michael H Kroll; Alessandra Ferrajoli |
16 | CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences | 2020 | Vitale C.; Strati P. |
17 | CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results | 2019 | D'Arena G.; Valvano L.; Vitale C.; Coscia M.; Statuto T.; Bellesi S.; Lamorte D.; Musto P.; Laurenti L.; D'Auria F. |
18 | Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia | 2021 | D'arena G.; Vitale C.; Coscia M.; Lamorte D.; Pietrantuono G.; Perutelli F.; D'auria F.; Statuto T.; Valvano L.; Tomasso A.; Griggio V.; Jones R.; Mansueto G.; Villani O.; D'agostino S.; Viglioglia V.; De Feo V.; Calapai F.; Mannucci C.; Sgambato A.; Efremov D.G.; Laurenti L. |
19 | CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia | 2018 | D'Arena, Giovanni*; Vitale, Candida; Rossi, Giovanni; Coscia, Marta; Omedè, Paola; D'Auria, Fiorella; Statuto, Teodora; Valvano, Luciana; Ciolli, Stefania; Gilestro, Milena; Molica, Stefano; Bellesi, Silvia; Topini, Giuseppe; Panichi, Valentina; Autore, Francesco; Innocenti, Idanna; Musto, Pellegrino; Deaglio, Silvia; Laurenti, Luca; Del Vecchio, Luigi |
20 | CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA | 2018 | D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L |